Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Body cell mass measured by bioelectrical impedance spectroscopy (BIS)
Baseline, mid of radio-/chemotherapy, end of radio-/chemotherapy, day 28 of convalescence period, day 49 of convalescence period
Rainer Fietkau, Prof. Dr.
Department of Radiotherapy University hospital of Erlangen
Germany: Ethics committee